PATH

$PATH

UiPath Inc.

Enterprise robotic process automation platform using AI to automate business workflows.

Technology
$11.23
-0.50 (-4.26%)
Day Range$11.22 - $12.14
Prev Close$11.73

PATH key facts as of November 14, 2026

Latest AI research report
PATH Stock: AI Growth and Valuation Risks (as of November 14, 2026)
StockAlpha report sentiment
Neutral (as of November 14, 2026)
Analyst consensus
Hold (1 Strong Buy, 2 Buy, 15 Hold, 0 Sell, 2 Strong Sell) (as of November 1, 2026)
Analyst price target
$15.13 mean (range $10.00 to $22.00) (as of November 20, 2026)
Sector
Technology
Analyst Rating
Hold
3 Buy / 15 Hold / 2 Sell
Price Target
$15.13
34.7% upside
Subscribers
0
Tracking this ticker
Latest Report

Analysis from Nov 14, 2026

NEUTRAL

PATH Stock: AI Growth and Valuation Risks

UiPath combines a large automation opportunity with an expanding focus on enterprise AI workflows, including a new healthcare collaboration with Google Cloud. But analyst sentiment is mostly Hold, and growth, competition and execution remain important variables for PATH.

Nov 14, 2026

PATH FAQ

What is StockAlpha's latest view on PATH?

StockAlpha's latest AI research report on UiPath Inc. (PATH), "PATH Stock: AI Growth and Valuation Risks", was published on November 14, 2026 and rates the overall sentiment as neutral. UiPath combines a large automation opportunity with an expanding focus on enterprise AI workflows, including a new healthcare collaboration with Google Cloud. But analyst sentiment is mostly Hold, and growth, competition and execution remain important variables for PATH.

When was the PATH research last updated?

The most recent PATH report was published on November 14, 2026.

What do analysts expect for PATH?

As of November 1, 2026, the analyst consensus on PATH is Hold (1 Strong Buy, 2 Buy, 15 Hold, 0 Sell, 2 Strong Sell). As of November 20, 2026, the analyst price target is $15.13 mean (range $10.00 to $22.00).

Is this PATH research investment advice?

No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.

Keep exploring